Dr. David Richard Pearson , MD
Dermatology โข Minneapolis, MN
909 Fulton St Se
Minneapolis, MN 55455
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on April 10, 2013; this date does not establish years in practice.
-
Published CMS data list 1,051 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 17003 โ Destruction of precancer skin growth, 2-14 growths: 377 service units.
- 99213 โ Established patient outpatient office visit: 186 service units.
- 17000 โ Destruction of precancer skin growth, 1 growth: 104 service units.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPTยฎ only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 13 records in the table ยท Guide: How to read Medicare Part B data
-
Published CMS data list 1,670 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Betamethasone Diprop Augmented (Betamethasone/Propylene Glyc) โ 146 prescription fills, including refills.
- Triamcinolone Acetonide โ 142 prescription fills, including refills.
- Ketoconazole โ 125 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 43 records in the table ยท Guide: How to read Medicare Part D prescriber data
-
Fewer Medicare Part B services than 60% of clinicians listed under Dermatology in Minneapolis, MN (2024, 30 clinicians with data). Median for this group: 1,252. Middle half: 549 to 2,603.
Fewer Medicare Part B services than 65% of clinicians listed under Dermatology in Minnesota (2024, 225 clinicians with data). Median for this group: 1,447. Middle half: 904 to 2,613.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 640 in 2020 to 1,051 in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2020โ2024.
Practice Location & Contact Primary Location
909 Fulton St Se
Minneapolis, MN 55455
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
NPPES lists 1 additional practice-address record in Philadelphia, PA. See the list
Source: CMS NPPES NPI Registry, practice location records; release date unavailable.
CMS Doctors and Clinicians lists 2 distinct group names: Fairview Express Care; University Of Minnesota Health Clinics And Surgery Center Inc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
Washington University School Of Medicine
2013
What Public CMS Data Show
Dermatology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
292 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider, 2024.
Medicare-allowed amount
About $57,482 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
Paid by Medicare
About $41,149 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
30-day fills
2,324 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$1,913,502 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $29,512.75 across 11 records.
By nature of payment
- Consulting Fee: $29,512.75 across 11 records.
Reporting-company totals
- Merck Sharp & Dohme LLC: $23,634.00 across 8 records.
- Pfizer Inc.: $3,733.75 across 2 records.
- AstraZeneca Pharmaceuticals LP: $2,145.00 across 1 record.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
13 years (graduated 2013)
CMS Doctors and Clinicians data list 2013 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
NPI first issued
2013
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, โDoes your provider accept Medicare as full payment?โ
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Enrolled in Medicare (PECOS)
Dr. Pearson has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Pearson as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Minneapolis and Minnesota
Billing and prescribing volume is not a quality rating.
Medicare Part B services
Fewer Medicare Part B services than 60% of clinicians listed under Dermatology in Minneapolis, MN (2024, 30 clinicians with data). Median for this group: 1,252. Middle half: 549 to 2,603.
Fewer Medicare Part B services than 65% of clinicians listed under Dermatology in Minnesota (2024, 225 clinicians with data). Median for this group: 1,447. Middle half: 904 to 2,613.
Medicare-allowed amount
A lower Medicare-allowed amount than 60% of clinicians listed under Dermatology in Minneapolis, MN (2024, 30 clinicians with data). Median for this group: $68,690. Middle half: $36,998 to $125,273.
A lower Medicare-allowed amount than 65% of clinicians listed under Dermatology in Minnesota (2024, 225 clinicians with data). Median for this group: $90,301. Middle half: $47,765 to $158,943.
Paid by Medicare
A lower Medicare payment amount than 60% of clinicians listed under Dermatology in Minneapolis, MN (2024, 30 clinicians with data). Median for this group: $49,286. Middle half: $26,391 to $95,021.
A lower Medicare payment amount than 65% of clinicians listed under Dermatology in Minnesota (2024, 225 clinicians with data). Median for this group: $61,548. Middle half: $33,917 to $114,176.
Medicare Part D prescriptions
More Part D prescriptions than 95% of clinicians listed under Dermatology in Minneapolis, MN (2024, 32 clinicians with data). Median for this group: 580. Middle half: 327 to 990.
More Part D prescriptions than 95% of clinicians listed under Dermatology in Minnesota (2024, 241 clinicians with data). Median for this group: 522. Middle half: 218 to 940.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Dermatology in Minneapolis, MN (2024, 32 clinicians with data). Median for this group: $118,128. Middle half: $19,624 to $567,095.
A higher Part D drug cost than 95% of clinicians listed under Dermatology in Minnesota (2024, 241 clinicians with data). Median for this group: $89,748. Middle half: $8,809 to $296,294.
43 active clinicians are listed under Dermatology with a practice address in Minneapolis, MN (331 in Minnesota).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Minneapolis
27.9% of these 43 clinicians have the CMS telehealth indicator.
72.1% of these 43 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 64% from 640 in 2020 to 1,051 in 2024.
- 2020: 640
- 2021: 163
- 2022: 480
- 2023: 994
- 2024: 1,051
-
Medicare-allowed amount
Medicare-allowed amount increased 63% from $35,288 in 2020 to $57,482 in 2024.
- 2020: $35,288
- 2021: $15,773
- 2022: $35,141
- 2023: $59,069
- 2024: $57,482
-
Paid by Medicare
Paid by Medicare increased 60% from $25,690 in 2020 to $41,149 in 2024.
- 2020: $25,690
- 2021: $11,926
- 2022: $25,361
- 2023: $41,608
- 2024: $41,149
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 140% from 695 in 2020 to 1,670 in 2024.
- 2020: 695
- 2021: 375
- 2022: 673
- 2023: 1,239
- 2024: 1,670
-
30-day fills
30-day fills increased 193% from 793 in 2020 to 2,324 in 2024.
- 2020: 793
- 2021: 480
- 2022: 874
- 2023: 1,705
- 2024: 2,324
-
Part D drug cost
Part D drug cost increased 498% from $319,859 in 2020 to $1,913,502 in 2024.
- 2020: $319,859
- 2021: $172,691
- 2022: $131,448
- 2023: $578,920
- 2024: $1,913,502
-
Industry payments (Open Payments)
Industry payments (Open Payments) increased 503% from $4,893.75 in 2021 to $29,512.75 in 2025.
- 2021: $4,893.75
- 2022: $11,161.30
- 2023: $2,416.67
- 2024: $13,527.08
- 2025: $29,512.75
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo ยท Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 โ December 31, 2025): 11 records totaling $29,512.75.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Merck Sharp & Dohme LLC |
Consulting Fee
Cash or cash equivalent
|
โ | General | $7,875.00 |
| Merck Sharp & Dohme LLC |
Consulting Fee
Cash or cash equivalent
|
โ | General | $5,875.00 |
| Merck Sharp & Dohme LLC |
Consulting Fee
Cash or cash equivalent
|
โ | General | $4,125.00 |
| Merck Sharp & Dohme LLC |
Consulting Fee
Cash or cash equivalent
|
โ | General | $3,250.00 |
| Pfizer Inc. |
Consulting Fee
Cash or cash equivalent
|
โ | General | $2,175.00 |
| AstraZeneca Pharmaceuticals LP |
Consulting Fee
Cash or cash equivalent
|
โ | General | $2,145.00 |
| Pfizer Inc. |
Consulting Fee
Cash or cash equivalent
|
โ | General | $1,558.75 |
| Merck Sharp & Dohme LLC |
Consulting Fee
Cash or cash equivalent
|
โ | General | $1,293.75 |
| Merck Sharp & Dohme LLC |
Consulting Fee
Cash or cash equivalent
|
โ | General | $675.00 |
| Merck Sharp & Dohme LLC |
Consulting Fee
Cash or cash equivalent
|
โ | General | $290.25 |
| Merck Sharp & Dohme LLC |
Consulting Fee
Cash or cash equivalent
|
โ | General | $250.00 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPTยฎ is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2017โ2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners โ by Provider and Service data, 2018โ2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
17003
Destruction of precancer skin growth, 2-14 growths
|
377 | 76 | $28.95 | $6.66 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
186 | 154 | $364.20 | $87.50 |
|
17000
Destruction of precancer skin growth, 1 growth
|
104 | 88 | $290.35 | $48.64 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
90 | 63 | $551.04 | $120.17 |
|
17110
Destruction of skin growth, 1-14 growths
|
73 | 65 | $497.05 | $113.15 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
54 | 54 | $458.63 | $107.56 |
|
88305
Pathology examination of tissue using a microscope, intermediate complexity
|
49 | 35 | $248.55 | $71.11 |
|
11102
Biopsy of related skin growth, first growth
|
39 | 38 | $446.41 | $87.12 |
|
99451
Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes
|
20 | 20 | $160.00 | $33.09 |
|
36415
Insertion of needle into vein for collection of blood sample
|
19 | 17 | $17.79 | $8.65 |
|
11103
Biopsy of related skin growth, each additional growth
|
17 | 14 | $221.24 | $49.48 |
|
85025
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
|
12 | 12 | $21.67 | $7.61 |
|
80053
Blood test, comprehensive group of blood chemicals
|
11 | 11 | $30.09 | $10.35 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Betamethasone Diprop Augmented | Betamethasone/Propylene Glyc | 146 | 4,439 | $8,360.35 | 74 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 142 | 5,274 | $2,173.42 | 90 |
| Ketoconazole | Ketoconazole | 125 | 3,776 | $2,148.37 | 48 |
| Dupixent Pen | Dupilumab | 102 | 3,318 | $416,954.94 | 13 |
| Prednisone | Prednisone | 91 | 4,128 | $754.55 | 28 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 71 | 3,874 | $3,419.50 | 29 |
| Clindamycin Phosphate | Clindamycin Phosphate | 67 | 2,091 | $2,209.73 | 31 |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 63 | 3,668 | $1,308.91 | 14 |
| Mycophenolate Mofetil | Mycophenolate Mofetil | 59 | 3,730 | $4,369.68 | 16 |
| Clobetasol Propionate | Clobetasol Propionate | 58 | 1,925 | $3,260.09 | 21 |
| Methotrexate | Methotrexate Sodium | 56 | 2,567 | $1,234.72 | 18 |
| Gabapentin | Gabapentin | 50 | 1,660 | $387.98 | โ |
| Fluorouracil | Fluorouracil | 44 | 1,377 | $2,736.15 | 28 |
| Otezla | Apremilast | 40 | 1,436 | $235,349.02 | โ |
| Humira(Cf) Pen | Adalimumab | 35 | 980 | $465,939.54 | โ |
| Metronidazole | Metronidazole | 30 | 805 | $811.76 | 11 |
| Pentoxifylline | Pentoxifylline | 30 | 1,530 | $1,090.93 | โ |
| Hydrocortisone | Hydrocortisone | 28 | 640 | $277.38 | 24 |
| Mupirocin | Mupirocin | 24 | 486 | $260.00 | 17 |
| Dapsone | Dapsone | 24 | 1,925 | $4,272.50 | โ |
| Ciclopirox | Ciclopirox | 23 | 555 | $767.25 | โ |
| Dupixent Syringe | Dupilumab | 23 | 784 | $100,829.83 | โ |
| Minocycline Hcl | Minocycline Hcl | 22 | 1,140 | $528.20 | โ |
| Tacrolimus | Tacrolimus | 22 | 562 | $2,297.79 | 14 |
| Hizentra | Immun Glob G(Igg)/Pro/Iga 0-50 | 22 | 595 | $192,839.46 | โ |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 207N00000X
A dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging.
NUCC Taxonomy Code: 207N00000X
A dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - DERMATOLOGY
I20180731001946
MN
1951535103
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
Fairview Express Care
10000 Zane Ave N, Brooklyn Park, MN 554431400
Phone: 7635286970
Fairview Express Care
10000 Zane Ave N, Brooklyn Park, MN 554431400
Phone: 7635725700
Fairview Express Care
14500 99th Ave N, Maple Grove, MN 553694738
Phone: 7638981000
Fairview Express Care
500 Harvard St Se, Minneapolis, MN 554550363
Phone: 6126727422
Fairview Express Care
717 Delaware St Se, Minneapolis, MN 554142959
Phone: 6126727422
University Of Minnesota Health Clinics And Surgery Center Inc
909 Fulton St Se, Minneapolis, MN 554554800
Phone: 6126727422
Secondary Practice Locations
3400 Civic Center Blvd Ste 1-330s
Philadelphia, PA 191045132
Phone: 2156622737
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Internal Medicine - Clinical Cardiac Electrophysiology
Doctor of Medicine (M.D.)
Internal Medicine - Gastroenterology
Doctor of Medicine (M.D.), Doctor of Philosophy (Ph.D.)
Urology
Doctor of Medicine (M.D.)
Radiology - Diagnostic Radiology
Doctor of Medicine (M.D.)
Internal Medicine - Hematology & Oncology
Doctor of Medicine (M.D.)
Internal Medicine - Infectious Disease
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Additional practice office at 3400 Civic Center Blvd Ste 1-330S, Philadelphia, PA 191045132
Dermatology (license number reported to NPPES: PA MD460085)
Registered at 909 FULTON ST SE, MINNEAPOLIS, MN 55455 (Tel: 6126727422)
Dermatology (license number reported to NPPES: MN 64164)
NPI status registered as active in NPPES database
Registered at 3400 CIVIC CENTER BLVD STE 1-330S, PHILADELPHIA, PA 191045132 (Tel: (215) 662-2737)
Registered at 3400 CIVIC CENTER BLVD, STE 1-330S, PHILADELPHIA, PA 19104 (Tel: (215) 662-2737)
Recorded as DAVID PEARSON, M.D.
Dermatology (license number reported to NPPES: PA MD460085)
NPI status registered as active in NPPES database
Registered at 13001 E 17TH PLACE, UNIVERSITY OF COLORADO SCHOOL OF MEDICINE GME, AURORA, CO 800452581 (Tel: 3037241784)
Registered at 13001 E 17TH PLACE, UNIVERSITY OF COLORADO SCHOOL OF MEDICINE GME, AURORA, CO 800452581 (Tel: 3037241784)
Recorded as DAVID PEARSON, M.D.
Student in an Organized Health Care Education/Training Program
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Dermatology Specialists in Minneapolis
- Dr. Richard Steinberg, MD
- Dr. Maria Hordinsky, MD
- Dr. Kimberly Bohjanen, MD
- Dr. Bruce Bart, MD
- Dr. Noah Goldfarb, MD
- Dr. Jill Moore, MD
Mailing Address
3400 Civic Center Blvd, Ste 1-330s
Philadelphia, PA 19104
Phone: 2156622737